Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples